Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 15962 | 614 | 48.1 | 76% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 205 | 20360 | PSYCHO-ONCOLOGY//QUALITY OF LIFE//QUALITY OF LIFE RESEARCH |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CHEMOBRAIN | Author keyword | 76 | 85% | 7% | 40 |
| 2 | CHEMOFOG | Author keyword | 11 | 100% | 1% | 6 |
| 3 | CHEMO BRAIN | Author keyword | 5 | 54% | 1% | 7 |
| 4 | PSYCHOSOCIAL EPIDEMIOL | Address | 5 | 11% | 6% | 38 |
| 5 | SUBJECTIVE COGNITIVE FUNCTION | Author keyword | 4 | 75% | 0% | 3 |
| 6 | CHEMO FOG | Author keyword | 4 | 56% | 1% | 5 |
| 7 | CHEMOTHERAPY RELATED COGNITIVE IMPAIRMENT | Author keyword | 3 | 100% | 0% | 3 |
| 8 | FACT COG | Author keyword | 3 | 100% | 0% | 3 |
| 9 | NEUROCOGNIT TRANSLAT | Address | 3 | 60% | 0% | 3 |
| 10 | SUBJECTIVE COGNITIVE FUNCTIONING | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | STANDARD DOSE CHEMOTHERAPY | 180 | 87% | 14% | 88 |
| 2 | RECEIVING ADJUVANT CHEMOTHERAPY | 35 | 29% | 16% | 101 |
| 3 | NEUROPSYCHOLOGIC IMPACT | 17 | 100% | 1% | 8 |
| 4 | DOSE CHEMOTHERAPY | 16 | 32% | 7% | 40 |
| 5 | CHEMOBRAIN | 13 | 67% | 2% | 12 |
| 6 | RESTORE ATTENTION | 9 | 55% | 2% | 11 |
| 7 | HIPPOCAMPAL CELL PROLIFERATION | 5 | 23% | 3% | 19 |
| 8 | DRUG ADRIAMYCIN | 4 | 67% | 1% | 4 |
| 9 | DOSE ADJUVANT CHEMOTHERAPY | 3 | 100% | 0% | 3 |
| 10 | NORMAL ADULT MICE | 2 | 67% | 0% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| A meta-analysis of the effects of chemotherapy on cognition in patients with cancer | 2013 | 21 | 20 | 95% |
| Cancer- and Cancer Treatment-Associated Cognitive Change: An Update on the State of the Science | 2012 | 53 | 68 | 84% |
| Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop | 2008 | 143 | 41 | 80% |
| Chemotherapy-Related Cognitive Dysfunction | 2012 | 49 | 82 | 78% |
| Clinical Characteristics, Pathophysiology, and Management of Noncentral Nervous System Cancer-Related Cognitive Impairment in Adults | 2015 | 1 | 192 | 62% |
| Clearing the Air: A Review of Our Current Understanding of "Chemo Fog" | 2013 | 13 | 82 | 93% |
| Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review | 2012 | 31 | 41 | 85% |
| Subjective cognitive dysfunction in breast cancer patients: a systematic review | 2010 | 56 | 58 | 66% |
| An Overview of Chemotherapy-Related Cognitive Dysfunction, or 'Chemobrain' | 2014 | 2 | 38 | 97% |
| Opening up the Window into "Chemobrain": A Neuroimaging Review | 2013 | 10 | 93 | 62% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PSYCHOSOCIAL EPIDEMIOL | 5 | 11% | 6.2% | 38 |
| 2 | NEUROCOGNIT TRANSLAT | 3 | 60% | 0.5% | 3 |
| 3 | MGH CANC NEUROL | 1 | 100% | 0.3% | 2 |
| 4 | WENKEBACH | 1 | 50% | 0.3% | 2 |
| 5 | CONCORD CANC | 1 | 33% | 0.5% | 3 |
| 6 | EA4700 | 1 | 33% | 0.5% | 3 |
| 7 | EXPT RADIAT | 1 | 25% | 0.5% | 3 |
| 8 | CANC COGNIT | 1 | 50% | 0.2% | 1 |
| 9 | CANC NURSING END LIFE CARE | 1 | 50% | 0.2% | 1 |
| 10 | CLIN POLICLIN RADIOTHER Y RADIOONCOL | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000133635 | CANCER RELATED FATIGUE//SYMPTOM CLUSTER//SYMPTOM CLUSTERS |
| 2 | 0.0000128331 | MANNHEIM GEN HOSP//PALLIAT HOME CARE UNIT BRAIN TUMOR PATIENTS//QLQ BN20 |
| 3 | 0.0000102777 | COGNITIVE LATE EFFECTS//INTRATHECAL METHOTREXATE//SOMNOLENCE SYNDROME |
| 4 | 0.0000096245 | RBANS//PRACTICE EFFECTS//CHANGE NORMS |
| 5 | 0.0000088888 | FACT BMT//PEDIATRIC SCT//PSYCHOL CONSULTAT LIAISON PSYCHIAT |
| 6 | 0.0000084537 | BRAIN TUMOR EXCELLENCE//FE 56 PARTICLES//NOVEL PLACE RECOGNITION |
| 7 | 0.0000076033 | BIOPHYS LIFE SCI//PROJECT SPECIAL COORDINATE FUNDS PROMOTING SCI//SPINE SYNAPSE DENSITY |
| 8 | 0.0000071910 | HLTH SERV ECON BRANCH//FINANCIAL TOXICITY//OUT OF POCKET COSTS |
| 9 | 0.0000066607 | FEAR OF RECURRENCE//FEAR OF CANCER RECURRENCE//FEAR OF PROGRESSION |
| 10 | 0.0000063085 | ACCELERATED RESPONSE//BODILY SENSATION//CARE TEAM |